Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1999 1
2002 1
2003 1
2013 1
2014 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

7 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Ovarian endometrioid cystadenoma"
Page 1
Ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary.
Lopez JM, Malpica A, Deavers MT, Ayala AG. Lopez JM, et al. Ann Diagn Pathol. 2003 Oct;7(5):300-5. doi: 10.1016/s1092-9134(03)00081-9. Ann Diagn Pathol. 2003. PMID: 14571433 Review.
The clinicopathologic and immunohistochemical findings of an unusual case of ovarian yolk sac tumor associated with endometrioid carcinoma and mucinous cystadenoma of the ovary are reported. ...Microscopic examination revealed that the tumor had a yolk sac co …
The clinicopathologic and immunohistochemical findings of an unusual case of ovarian yolk sac tumor associated with endometrioid …
Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates.
Gurung A, Hung T, Morin J, Gilks CB. Gurung A, et al. Histopathology. 2013 Jan;62(1):59-70. doi: 10.1111/his.12033. Histopathology. 2013. PMID: 23240670 Review.
There are five subtypes of ovarian carcinoma that are sufficiently distinct and well-characterized that they should be considered to be different diseases, i.e. high-grade serous, clear cell, endometrioid, mucinous and low-grade serous, from most to least common, re …
There are five subtypes of ovarian carcinoma that are sufficiently distinct and well-characterized that they should be considered to …
Papillary Cystadenofibroma of Fallopian Tube: Case Report with a Literature Review.
Hodzic E, Pusina S, Bajramagic S, Salibasic M, Holjan S. Hodzic E, et al. Med Arch. 2020 Feb;74(1):73-76. doi: 10.5455/medarh.2020.74.73-76. Med Arch. 2020. PMID: 32317841 Free PMC article. Review.
According to clasification of World health organisation (WHO), papillomas, cystadenoma, adenofibroma, cystadenofibroma (CAF), metaplastic papillary tumors and endometrioid polyps belong to group of benign tumors. ...AIM: The aim of this article is to show a rare cas …
According to clasification of World health organisation (WHO), papillomas, cystadenoma, adenofibroma, cystadenofibroma (CAF), metapla …
Detection and clinical correlations of ras gene mutations in human ovarian tumors.
Varras MN, Sourvinos G, Diakomanolis E, Koumantakis E, Flouris GA, Lekka-Katsouli J, Michalas S, Spandidos DA. Varras MN, et al. Oncology. 1999;56(2):89-96. doi: 10.1159/000011946. Oncology. 1999. PMID: 9949292
No mutation of K-, H- and N-ras genes was detected in 23 ovarian cystadenomas. In 1 out of 3 borderline ovarian tumors (33%) we found an H-ras gene mutation. ...Analysis of the results revealed no significant correlation between ras gene mutations and clinico …
No mutation of K-, H- and N-ras genes was detected in 23 ovarian cystadenomas. In 1 out of 3 borderline ovarian tumors …
Differential expression of apoptosis associated genes bax and bcl-2 in ovarian cancer.
Marx D, Binder C, Meden H, Lenthe T, Ziemek T, Hiddemann T, Kuhn W, Schauer A. Marx D, et al. Anticancer Res. 1997 May-Jun;17(3C):2233-40. Anticancer Res. 1997. PMID: 9216694
In the present study, tumor tissue from 215 patients with ovarian cancer was immunohistochemically analysed for Bax- and Bcl-2-expression. ...It may be speculated, that alteration of the Bax/Bcl-2-balance may influence the clinical course by deregulation of programm …
In the present study, tumor tissue from 215 patients with ovarian cancer was immunohistochemically analysed for Bax- and Bcl-2-expres …
u-PA expression in benign, borderline and malignant ovarian tumors.
Kiziridou AD, Toliou T, Stefanou D, Agnantis N. Kiziridou AD, et al. Anticancer Res. 2002 Mar-Apr;22(2A):985-90. Anticancer Res. 2002. PMID: 12014682
Benign tumors (n = 20) showed a variety of staining. The observation of randomly positive u-PA stromal cells is noteworthy. The percentage of u-PA-positive tumors was higher in carcinomas than in other tumors. ...In conclusion there are noticeable differences in u-PA expre …
Benign tumors (n = 20) showed a variety of staining. The observation of randomly positive u-PA stromal cells is noteworthy. The perce …
An unusual case of a borderline Brenner tumor associated with bilateral serous cystadenoma and endometrial carcinoma.
Cruz-Galarza D, Pérez-Rodríguez O, Laboy-Torres J, Gutiérrez-Rivera S. Cruz-Galarza D, et al. Bol Asoc Med P R. 2014;106(1):54-6. Bol Asoc Med P R. 2014. PMID: 24791367
Brenner tumor accounts for 1.5 to 2.5% of ovarian tumors. Nearly all are benign and 1% malignant. Less than twenty-five cases of borderline Brenner tumor have been reported worldwide. Our case is the first one related to a bilateral ovarian serous cystadenofibroma a …
Brenner tumor accounts for 1.5 to 2.5% of ovarian tumors. Nearly all are benign and 1% malignant. Less than twenty-five cases of bord …